Woonsocket, R.I.-based CVS Health outlined five strategies the company deployed in its retail pharmacy services for a consumer-driven approach to healthcare, according to DrugStoreNews.
Pharmacy
The market for laparoscopy devices, as reported by Transparency Market Research, is projected to reach $13,152.9 million in 2018, a substantial increase from its worth of $6,968 million in 2011.
Pacira Pharmaceuticals headquartered in Parsippany, N.J., reported the success of its EXPAREL, in the United States with net product sales totaling at $44.9 million in the second quarter of 2014 compared with $15.2 million in the second quarter of 2013.
The Government Accountability Office released a report on drug shortages, which found anesthetic and central nervous system drugs are among the class of drugs experiencing the highest frequently of shortages, at 17 percent of all shortages, according to an American…
The anesthesia drug market is expected to be valued at $7 billion by 2015, according to a Markets and Markets report.
Advertisement
Blue Shield of California is the latest major insurer to scale back coverage for proton beam therapy for early stage prostate cancer, according to a Wall Street Journal report.
Sagent Pharmaceuticals recalled three lots of Vecuronium Bromide for injection, a neuromuscular blocking agent used with general anesthesia to provide muscle relaxation or mechanical ventilation.
Irvine, Calif.-based Masimo released three clinical studies that evaluate its noninvasive patient monitoring technologies and presented them at the International Anesthesia Research Society's Annual Meeting in San Diego.
Physician Office Partners announced it will now provide an anesthesia billing solution.
With the recent enactment of the Multiple Procedure Payment Reduction and the increased equipment-utilization rate (used to calculate Medicare reimbursement) contained in the American Taxpayer Relief Act, reimbursement pressures on physician-owned imaging centers are intensifying. These centers, many of which…